Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis-Reference-Cited by-同舟云学术

Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis

Published:2022-10 Issue:1 Volume:30 Page:162-171
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Andersen Johanna Balslev¹^ORCID,Sellebjerg Finn²³,Magyari Melinda¹²³^ORCID

Affiliation:

1. Danish Multiple Sclerosis Registry, Department of Neurology Copenhagen University Hospital–Rigshospitalet Glostrup Denmark

2. Danish Multiple Sclerosis Center, Department of Neurology Copenhagen University Hospital–Rigshospitalet Glostrup Denmark

3. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15559

Reference41 articles.

1. EMA.European Medicines Agency ‐ Find medicine ‐ Aubagio http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002514/human_med_001645.jsp&mid=WC0b01ac058001d124(accessed 10 April 2018).

2. EMA.EMA Mavenclad. Accessed February 9 2020.https://www.ema.europa.eu/en/documents/product‐information/mavenclad‐epar‐product‐information_en.pdf

3. Dynamics of immunoglobulins at the feto-maternal interface

4. IgG Placental Transfer in Healthy and Pathological Pregnancies

5. Natalizumab Use During the Third Trimester of Pregnancy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy;Clinical and Translational Neuroscience;2024-08-01

2. Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021;Multiple Sclerosis Journal;2024-01-27

3. Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry;Multiple Sclerosis Journal;2024-01-02

4. Interferon-beta exposure in-utero and the risk of infections in early childhood;Multiple Sclerosis and Related Disorders;2023-09

5. Multiple Sklerose: Disease Modifying Drugs (DMDs) in der Schwangerschaft?;Neurologie up2date;2023-06